Telemus Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Telemus Capital, LLC

$1.2 Billion
Q4 2023

A detailed history of Telemus Capital, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Telemus Capital, LLC holds 800 shares of REGN stock, worth $840,824. This represents 0.06% of its overall portfolio holdings.

Number of Shares

800

Previous 799 0.13%

Holding current value

$840,824

Previous $657,000 6.85%

% of portfolio

0.06%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$775.18 - $881.7 $775 - $881	1 Added 0.13%	800 $702,000
Q3 2023 Oct 25, 2023	SELL	$692.45 - $844.37 $2,077 - $2,533	-3 Reduced 0.37%	799 $657,000
Q2 2023 Jul 10, 2023	BUY	$700.03 - $830.35 $154,706 - $183,507	221 Added 38.04%	802 $576,000
Q1 2023 Apr 11, 2023	SELL	$680.49 - $826.97 $14,290 - $17,366	-21 Reduced 3.49%	581 $477,000
Q4 2022 Jan 11, 2023	BUY	$705.89 - $766.39 $20,470 - $22,225	29 Added 5.06%	602 $0

Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $110,766 - $149,245	202 Added 54.45%	573 $339,000
Q1 2022 Apr 06, 2022	BUY	$595.12 - $698.43 $3,570 - $4,190	6 Added 1.64%	371 $259,000
Q4 2021 Feb 01, 2022	SELL	$543.48 - $670.97 $1,086 - $1,341	-2 Reduced 0.54%	365 $231,000
Q3 2021 Oct 27, 2021	SELL	$574.03 - $680.96 $696,298 - $826,004	-1,213 Reduced 76.77%	367 $222,000
Q2 2021 Aug 09, 2021	BUY	$472.8 - $558.54 $70,920 - $83,781	150 Added 10.49%	1,580 $882,000
Q1 2021 Apr 20, 2021	BUY	$446.73 - $548.2 $254,636 - $312,474	570 Added 66.28%	1,430 $693,000
Q4 2020 Jan 28, 2021	SELL	$478.3 - $607.98 $338,158 - $429,841	-707 Reduced 45.12%	860 $415,000
Q3 2020 Nov 02, 2020	BUY	$544.75 - $658.21 $542,026 - $654,918	995 Added 173.95%	1,567 $940,000
Q1 2020 Jun 05, 2020	BUY	$336.18 - $494.43 $192,294 - $282,813	572 New	572 $351,000
Q1 2018 Apr 27, 2018	SELL	$315.82 - $393.78 $12,632 - $15,751	-40 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$358.63 - $469.95 $1.44 Million - $1.88 Million	-4,004 Reduced 99.01%	40 $15,000
Q2 2017 Apr 03, 2018	BUY	N/A	4,044	4,044 $1.99 Million

Others Institutions Holding REGN

# of Institutions

1,424

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Account

Telemus Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History